RecruitingNCT00919217

Exploratory Study on the Timing of Multiple Sclerosis (MS) Symptoms

Exploratory Study on the Timing of MS Symptoms


Sponsor

University of Louisville

Enrollment

80 participants

Start Date

Aug 1, 2008

Study Type

OBSERVATIONAL

Conditions

Summary

The investigators' overall hypothesis is that appearance or worsening of relapsing-remitting multiple sclerosis (RR-MS) symptoms are affected by various factors including stress, hormonal cycles, illness and missed medications.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This study is researching whether the timing and nature of multiple sclerosis (MS) symptoms are related to hormonal and immune changes throughout the menstrual cycle in women with relapsing-remitting MS. **You may be eligible if...** - You are a woman - You have been diagnosed with relapsing-remitting multiple sclerosis (the most common type of MS) **You may NOT be eligible if...** - You are male - You do not have a relapsing-remitting MS diagnosis - You have another autoimmune disease or fibromyalgia - You are menopausal or post-menopausal (naturally or surgically) - You have been pregnant in the past year or are currently breastfeeding - You have a history of chemotherapy - You are on experimental medications - You have used steroids in the last 30 days Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University of Louisville (recruiting nationwide)

Louisville, Kentucky, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00919217


Related Trials